Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01)
This study has been completed.
Study NCT00308269   Information provided by Merck Sharp & Dohme Corp.

First Received on March 27, 2006.   Last Updated on May 21, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial